Literature DB >> 4327587

Priming: a nonantiviral function of interferon.

W E Stewart, L B Gosser, R Z Lockart.   

Abstract

No interferon is made by L cells when they are infected with MM virus. However, several thousand units of interferon are produced when interferon-treated L cells are infected with MM virus. We call the conversion of cells, from nonproducers to producers, priming. The time required for cells to become fully primed is dependent on the interferon concentration with which they are incubated. Primed cells produced interferon earlier than normal cells stimulated by other inducers. Cells which were exposed to interferon in the presence of inhibitors of protein synthesis became fully primed yet developed no virus resistance. Also, primed cells produced interferon in response to low concentrations of polyriboinosinic acid . polyribocytidylic acid that did not induce interferon in normal cells. Therefore, priming appears to be a function of interferon separable from its antiviral activity. Several other picornaviruses that failed to induce interferon in L cells, human embryonic lung cells, or monkey kidney cells did induce interferon when these cells had been primed by homologous interferons.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4327587      PMCID: PMC356199     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Immunology of interferons. II. Heterospecific activities of human interferons and their neutralization by antibody.

Authors:  R E Levy-Koenig; R R Golgher; K Paucker
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

2.  Effect of interferon on early interferon production.

Authors:  H B Levy; C E Buckler; S Baron
Journal:  Science       Date:  1966-05-27       Impact factor: 47.728

3.  Enhancement of interferon synthesis by polyinosinic-polycytidylic acid in L cells pretreated with interferon.

Authors:  I Rosztóczy; I Mécs
Journal:  Acta Virol       Date:  1970-09       Impact factor: 1.162

4.  Enhancement of the infectivity of rhinovirus ribonucleic acid by diethylaminoethyl dextran.

Authors:  M Fiala; B Saltzman
Journal:  Appl Microbiol       Date:  1969-01

Review 5.  Cellular resistance to induction of interferon.

Authors:  K Paucker; M Boxaca
Journal:  Bacteriol Rev       Date:  1967-06

6.  Inhibition of induction of interferon synthesis in L-cells pretreated with interferon.

Authors:  J S Youngner; J V Hallum
Journal:  Virology       Date:  1969-03       Impact factor: 3.616

7.  An explanation for increased interferon production at low multiplicities of infection.

Authors:  R M Goorha; G E Gifford
Journal:  Proc Soc Exp Biol Med       Date:  1970-10

8.  Effect of interferon treatment on interferon production.

Authors:  R M Friedman
Journal:  J Immunol       Date:  1966-05       Impact factor: 5.422

9.  Basis for variable response of arboviruses to guanidine treatment.

Authors:  R M Friedman
Journal:  J Virol       Date:  1970-11       Impact factor: 5.103

10.  Regulation of cellular interferon production: enhancement by antimetabolites.

Authors:  Y H Tan; J A Armstrong; Y H Ke; M Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

View more
  57 in total

1.  Multisurface glass roller bottle for growth of animal cells in culture.

Authors:  E Knight
Journal:  Appl Environ Microbiol       Date:  1977-03       Impact factor: 4.792

2.  Increased interferon production in human cells irradiated with ultraviolet light.

Authors:  L W Mozes; E A Havell; M L Gradoville; J Vilcek
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

3.  Production of interferon-beta in a culture of fibroblast cells on some polymeric films.

Authors:  A Higuchi; M Yoshida; T Ohno; T Asakura; M Hara
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

4.  Priming activity of mouse interferon: effect on interferon messenger RNA synthesis.

Authors:  S Saito; T Matsuno; T Sudo; E Furuya; S Kohno
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

5.  Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon production.

Authors:  Anne P Liao; Mohammad Salajegheh; Chris Morehouse; Remedios Nazareno; Ronald G Jubin; Bahija Jallal; Yihong Yao; Steven A Greenberg
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

6.  Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes.

Authors:  Yong Zhao; Dongsheng Xu; Yanjun Jiang; Luwen Zhang
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

7.  Mechanism of interferon action: inhibition of viral messenger ribonucleic acid translation in L-cell extracts.

Authors:  R M Friedman; D H Metz; R M Esteban; D R Tovell; L A Ball; I M Kerr
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

8.  Cellular alteration by interferon: a virus-free system for assaying interferon.

Authors:  W E Stewart; E De Clercq; P De Somer
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

9.  Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid.

Authors:  W E Stewart; E De Clercq; A Billiau; J Desmyter; P De Somer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

10.  Electrophoretically pure mouse interferon exerts multiple biologic effects.

Authors:  I Gresser; J De Maeyer-Guignard; M G Tovey; E De Maeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.